Biological drugs in auto immune diseases


Biologic therapies  rheumatologic diseases, which are targeted at molecules tangled in the mechanisms of  immune system, offer a substitute to the present treatment approaches of disease-modifying anti-rheumatic drugs and immunosuppressive medications. Biologics, or biological response modifiers, might be given to treat autoimmune diseases, including many types arthritis, such as rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. Biologics work by unsettling the inflammation process that leads to joint pain and destruction. Non-steroidal anti-inflammatory drugs (NSAIDs), glucocorticoids, disease-modifying antirheumatic drugs (DMARDs) are conservatively used in dealing with autoimmune inflammatory diseases.



 


    Related Conference of Biological drugs in auto immune diseases

    April 17-18, 2024

    14th International Conference on Chemistry Meeting

    Paris, France
    June 25-26, 2024

    13th World Congress on Chromatography

    Toronto, Canada
    August 22-23, 2024

    16th International Conference on Clinical Chemistry

    Berlin, Germany
    December 18-19, 2024

    4th International Conference on Petrochemistry and Natural Gas

    Amsterdam, Netherlands

    Biological drugs in auto immune diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in